(BCH) Banco De Chile - Overview
Sector: Financial ServicesIndustry: Banks - Regional | Exchange NYSE (USA) | Currency USD | Market Cap: 18.830m | Total Return 44.3% in 12m
Stock: Banking, Loans, Investments, Insurance, Trading
| Risk 5d forecast | |
|---|---|
| Volatility | 36.5% |
| Relative Tail Risk | 2.90% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.27 |
| Alpha | 32.47 |
| Character TTM | |
|---|---|
| Beta | 0.694 |
| Beta Downside | 0.320 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.59% |
| CAGR/Max DD | 1.66 |
EPS (Earnings per Share)
Revenue
Description: BCH Banco De Chile March 04, 2026
Banco de Chile operates as a diversified commercial bank in Chile. It offers a broad range of financial services to retail, wholesale, and institutional clients.
The Retail segment provides consumer banking products including loans, deposits, and credit cards. The Wholesale segment focuses on corporate clients, offering commercial loans and investment banking services. Banks typically generate revenue from interest income on loans and fees for services.
The Treasury segment manages the banks financial assets and liabilities, including foreign currency trading and derivative instruments. The Subsidiaries segment extends services into insurance, brokerage, and payment solutions. Diversified banks often leverage multiple revenue streams to mitigate risk.
For more detailed financial analysis, consider exploring ValueRays comprehensive reports.
Headlines to watch out for
- Chilean economic stability directly impacts loan demand and credit quality
- Interest rate fluctuations influence net interest margin
- Regulatory changes in banking sector affect compliance costs
- Competition from fintechs erodes traditional banking market share
- Commodity price volatility impacts corporate loan portfolio performance
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 1192.26b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA 0.04 > 1.0 |
| NWC/Revenue: -460.2% < 20% (prev 49.20%; Δ -509.4% < -1%) |
| CFO/TA 0.07 > 3% & CFO 4045.02b > Net Income 1192.26b |
| Net Debt (9727.07b) to EBITDA (1607.49b): 6.05 < 3 |
| Current Ratio: 0.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (505.2m) vs 12m ago 0.02% < -2% |
| Gross Margin: 87.38% > 18% (prev 0.69%; Δ 8.67k% > 0.5%) |
| Asset Turnover: 5.70% > 50% (prev 7.37%; Δ -1.67% > 0%) |
| Interest Coverage Ratio: 1.56 > 6 (EBITDA TTM 1607.49b / Interest Expense TTM 969.64b) |
Altman Z'' -1.21
| A: -0.26 (Total Current Assets 8078.73b - Total Current Liabilities 22003.49b) / Total Assets 54100.90b |
| B: 0.05 (Retained Earnings 2677.10b / Total Assets 54100.90b) |
| C: 0.03 (EBIT TTM 1512.38b / Avg Total Assets 53098.17b) |
| D: 0.12 (Book Value of Equity 5799.53b / Total Liabilities 48301.37b) |
| Altman-Z'' Score: -1.21 = CCC |
Beneish M
| DSRI: none (Receivables none/195.36b, Revenue 3026.04b/3837.07b) |
| GMI: 0.79 (GM 87.38% / 69.16%) |
| AQI: 0.89 (AQ_t 0.85 / AQ_t-1 0.96) |
| SGI: 0.79 (Revenue 3026.04b / 3837.07b) |
| TATA: -0.05 (NI 1192.26b - CFO 4045.02b) / TA 54100.90b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of BCH shares?
Over the past week, the price has changed by +2.46%, over one month by -9.79%, over three months by +1.88% and over the past year by +44.31%.
Is BCH a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 7
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the BCH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 38.2 | -2.3% |
| Analysts Target Price | 38.2 | -2.3% |
BCH Fundamental Data Overview March 23, 2026
P/E Forward = 27.7008
P/S = 5.7476
P/B = 2.9787
P/EG = 9.2387
Revenue TTM = 3026.04b USD
EBIT TTM = 1512.38b USD
EBITDA TTM = 1607.49b USD
Long Term Debt = 13955.26b USD (from longTermDebt, two quarters ago)
Short Term Debt = 3575.88b USD (from shortTermDebt, last quarter)
Debt = 11384.95b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9727.07b USD (from netDebt column, last quarter)
Enterprise Value = 3325.04b USD (18.83b + Debt 11384.95b - CCE 8078.73b)
Interest Coverage Ratio = 1.56 (Ebit TTM 1512.38b / Interest Expense TTM 969.64b)
EV/FCF = -7.61x (Enterprise Value 3325.04b / FCF TTM -436.73b)
FCF Yield = -13.13% (FCF TTM -436.73b / Enterprise Value 3325.04b)
FCF Margin = -14.43% (FCF TTM -436.73b / Revenue TTM 3026.04b)
Net Margin = 39.40% (Net Income TTM 1192.26b / Revenue TTM 3026.04b)
Gross Margin = 87.38% ((Revenue TTM 3026.04b - Cost of Revenue TTM 381.92b) / Revenue TTM)
Gross Margin QoQ = none% (prev 66.56%)
Tobins Q-Ratio = 0.06 (Enterprise Value 3325.04b / Total Assets 54100.90b)
Interest Expense / Debt = 2.06% (Interest Expense 235.09b / Debt 11384.95b)
Taxrate = 21.74% (73.78b / 339.32b)
NOPAT = 1183.54b (EBIT 1512.38b * (1 - 21.74%))
Current Ratio = 0.37 (Total Current Assets 8078.73b / Total Current Liabilities 22003.49b)
Debt / Equity = 1.96 (Debt 11384.95b / totalStockholderEquity, last quarter 5799.53b)
Debt / EBITDA = 6.05 (Net Debt 9727.07b / EBITDA 1607.49b)
Debt / FCF = -22.27 (negative FCF - burning cash) (Net Debt 9727.07b / FCF TTM -436.73b)
Total Stockholder Equity = 5610.96b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.25% (Net Income 1192.26b / Total Assets 54100.90b)
RoE = 21.25% (Net Income TTM 1192.26b / Total Stockholder Equity 5610.96b)
RoCE = 7.73% (EBIT 1512.38b / Capital Employed (Equity 5610.96b + L.T.Debt 13955.26b))
RoIC = 6.37% (NOPAT 1183.54b / Invested Capital 18574.55b)
WACC = 1.63% (E(18.83b)/V(11403.78b) * Re(8.42%) + D(11384.95b)/V(11403.78b) * Rd(2.06%) * (1-Tc(0.22)))
Discount Rate = 8.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 123.6%
[DCF] Fair Price = unknown (Cash Flow -436.73b)
EPS Correlation: -65.04 | EPS CAGR: -4.44% | SUE: -0.26 | # QB: 0
Revenue Correlation: -47.26 | Revenue CAGR: -58.54% | SUE: -0.00 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.68 | Chg7d=+0.000 | Chg30d=-0.008 | Revisions Net=+0 | Analysts=4
EPS current Year (2026-12-31): EPS=2.84 | Chg7d=+0.000 | Chg30d=+0.010 | Revisions Net=+0 | Growth EPS=+3.4% | Growth Revenue=+5.9%
EPS next Year (2027-12-31): EPS=3.14 | Chg7d=+0.000 | Chg30d=+0.076 | Revisions Net=+2 | Growth EPS=+10.5% | Growth Revenue=+6.9%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 1.5% (Discount Rate 8.4% - Earnings Yield 6.9%)
[Growth] Growth Spread = +0.2% (Analyst 1.7% - Implied 1.5%)